Astria Therapeutics, Inc. (NASDAQ: ATXS), a biopharmaceutical company dedicated to advancing treatments for allergic and immunological diseases, has announced its partnership with Ypsomed for developing an autoinjector for STAR-0215. This collaboration aims to enhance the delivery system for STAR-0215, a…
Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has provided an update regarding the March 2024 recall of its t:connect mobile app for Apple iOS devices. The recall addresses an issue causing rapid depletion of the t:slim X2 insulin pump battery, potentially…
Zura Bio Limited (Nasdaq: ZURA), a clinical-stage immunology company specializing in dual-pathway antibodies for autoimmune and inflammatory diseases, has completed its exchange offer and consent solicitation for its outstanding IPO warrants. This includes both public warrants, which trade under the…
Masimo (NASDAQ: MASI) has announced that the Masimo W1® medical watch has received FDA 510(k) clearance for integration with the Masimo SafetyNet® telemonitoring system. The Masimo W1®—the first medical watch to offer continuous oxygen saturation (SpO2) and pulse rate (PR)…
UptimeHealth, a leader in healthcare technology solutions, is excited to announce a new partnership with Darby Dental Supply, a major dental distributor in the U.S. This collaboration represents a major advancement in improving operational efficiency and compliance for dental practices…
Alpha Cognition Inc. (OTCQB: ACOG) (CSE: ACOG) has announced its financial results for the second quarter and six months ending June 30, 2024, along with a corporate update. CEO Michael McFadden highlighted the FDA’s approval of ZUNVEYL, a major achievement…
CharmHealth, a top provider of healthcare technology solutions, has introduced its inaugural internship program designed to cultivate the next generation of healthtech leaders. This paid internship offers participants hands-on experience and insight into various facets of the healthcare field. The…
Prothena Corporation plc (NASDAQ:PRTA), a leader in protein dysregulation-based therapies, reported its financial results for Q2 and the first half of 2024, alongside key business updates. Second Quarter and 2024 Highlights: Pipeline Updates: Financial Guidance Update:Prothena expects 2024 net cash…
Insulet Corporation (NASDAQ: PODD), a global leader in tubeless insulin pump technology with its Omnipod® products, today announced its financial results for the quarter ending June 30, 2024. Second Quarter Financial Highlights: Recent Strategic Highlights: Jim Hollingshead, President and CEO,…
PhotoPharmics, a leader in phototherapy for neurodegenerative diseases, has announced the enrollment of the first 100 participants in its Light for PD clinical trial. This milestone is a key step in assessing Celeste, the company’s FDA Breakthrough light therapy device…
Nucleus Biologics, The Cell Performance Company™, a top provider of custom cell culture media and buffers for the cell and gene therapy sector, is excited to introduce its new QuickStart Media™ platform. This innovative platform accelerates the formulation and manufacturing…
Verastem Oncology, a biopharmaceutical firm dedicated to developing new cancer treatments, has provided an update on its business activities and financial performance for the second quarter ended June 30, 2024. Dan Paterson, the company’s President and CEO, highlighted significant advancements:…